Ji K, Liang H, Ren M, Ge X, Mi H, Pan L, Yu H
Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors under clinical evaluation for obesity and type 2 diabetes
the present invention describes two methods for the synthesis of Semaglutide: the route for sequential coupling is: the synthesis route of the present invention comprises the following steps: the resin to which Fmoc-Gly-OH is attached in step 1) can be chosen from wang resin or 2-CTC resin
Thanks so much
ISO 22000:2018,WHO-GMP;OHSAS 45001;2015 Related Products Explore Related Categories More Products From This Seller Seller Details GST - 09AABCV3624M3ZZ Trusted Seller Greater Noida, Uttar Pradesh Accepts only Foreign inquiries Director Marketing Mrs Anu Bansal Members since 7 Years Address Plant Address : B No, B-1/A, EPIP Site V, Kasana, Road No